factually
Index/Organizations/European Society for Medical Oncology

European Society for Medical Oncology

Professional organisation

Fact-Checks

3 results
Jan 16, 2026
Most Viewed

How do oncology guideline bodies (NCCN, ESMO, ASCO) formally address repurposed antiparasitic drugs in recent statements?

No explicit, formal endorsements or dedicated recommendations for repurposed antiparasitic drugs appear in the recent guideline summaries and updates from the National Comprehensive Cancer Network (NC...

Jan 22, 2026

How should management (staging, systemic therapy, trials) change for patients with high‑grade prostate cancer and very low PSA?

(Grade Group 4–5 or Gleason ≥8) with a deceptively low serum PSA should trigger more aggressive staging and consideration of treatment intensification rather than reassurance; modern imaging (includin...

Dec 12, 2025

Have major oncology clinical guidelines (NCCN, ESMO, ASCO) updated recommendations based on ivermectin cancer trials?

Major oncology guideline bodies (NCCN, ESMO, ASCO) have not adopted ivermectin as a recommended cancer treatment; available sources report only early-phase trials and preclinical work, with one active...